[HTML][HTML] The identification, assessment and management of difficult-to-treat depression: an international consensus statement

RH McAllister-Williams, C Arango, P Blier… - Journal of Affective …, 2020 - Elsevier
Background Many depressed patients are not able to achieve or sustain symptom remission
despite serial treatment trials–often termed “treatment resistant depression”. A broader …

Prevalence of suicidal ideation and planning in patients with major depressive disorder: a meta-analysis of observation studies

H Cai, Y Jin, S Liu, Q Zhang, L Zhang, T Cheung… - Journal of affective …, 2021 - Elsevier
Background Suicidal ideation (SI) and suicide planning (SP) are associated with an
increased risk of future suicide. We performed a meta-analysis of observational studies to …

Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: results of a …

DF Ionescu, DJ Fu, X Qiu, R Lane, P Lim… - International Journal …, 2021 - academic.oup.com
Background Patients with major depressive disorder (MDD) having active suicidal ideation
with intent require immediate treatment. Methods This double-blind study (ASPIRE II) …

[HTML][HTML] Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN …

N Zaki, L Chen, R Lane, T Doherty… - …, 2023 - nature.com
Patients with treatment-resistant depression (TRD) have higher rates of relapse and
pronounced decreases in daily functioning and health-related quality of life compared to …

Results of the European Group for the Study of Resistant Depression (GSRD)—basis for further research and clinical practice

L Bartova, M Dold, A Kautzky, C Fabbri… - The World Journal of …, 2019 - Taylor & Francis
Objectives: The overview outlines two decades of research from the European Group for the
Study of Resistant Depression (GSRD) that fundamentally impacted evidence-based …

Decreases in suicidality following psychedelic therapy: A meta-analysis of individual patient data across clinical trials

RJ Zeifman, D Yu, N Singhal, G Wang… - The Journal of clinical …, 2022 - psychiatrist.com
Objective: Suicide is a global health concern, and innovative interventions that target
suicidality are needed. While psychedelic therapy shows promise for a range of mental …

[HTML][HTML] Prevalence and impact of treatment-resistant depression in Latin America: a prospective, observational study

B Soares, G Kanevsky, CT Teng, R Pérez-Esparza… - Psychiatric …, 2021 - Springer
Approximately one-third of patients with major depressive disorder (MDD) have treatment-
resistant depression (TRD). The TRAL study will evaluate the prevalence and impact of TRD …

[HTML][HTML] Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database

C Kraus, A Kautzky, V Watzal, A Gramser… - Journal of affective …, 2023 - Elsevier
Background Individuals with major depressive disorder (MDD) are at higher risk for obesity.
In turn, weight gain is a predisposing factor for depression. Although clinical data are sparse …

[HTML][HTML] All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population

G Li, D Fife, G Wang, JJ Sheehan, R Bodén… - Annals of General …, 2019 - Springer
Background Treatment-resistant depression (TRD) may represent a substantial proportion of
major depressive disorder (MDD); however, the risk of mortality in TRD is still incompletely …

Association between thyroid hormones and comorbid psychotic symptoms in patients with first-episode and drug-naïve major depressive disorder

P Peng, Q Wang, H Ren, Y Zhou, Y Hao, S Chen… - Psychiatry …, 2023 - Elsevier
Thyroid dysfunction is common in major depressive disorder (MDD) patients; however, its
relationship with psychotic depression (PD) remains unclear. We aimed to assess thyroid …